{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:16Z","timestamp":1794248596581,"version":"4.9.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation","award":["81970738"],"award-info":[{"award-number":["81970738"]}]},{"name":"Natural science foundation project of Sichuan","award":["2024NSFSC0599"],"award-info":[{"award-number":["2024NSFSC0599"]}]},{"name":"the Key Research and Development Program of Chengdu","award":["2023-YF09-00052-SN"],"award-info":[{"award-number":["2023-YF09-00052-SN"]}]},{"name":"Universal Application Program of Health Commission of Sichuan Province","award":["no. 21PJ047"],"award-info":[{"award-number":["no. 21PJ047"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,21]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Interleukin-18 (IL-18), an IL-1 family cytokine with potent ability to induce interferon gamma production and enhance Th1 response, was elevated in a group of autoimmune diseases including primary Sj\u00f6gren syndrome (pSS). IL-18 dysregulation can contribute to the pathogenesis of these disorders by exerting function in innate and adaptive immunity. This study is aimed at comparing the level of IL-18 in pSS patients and explored the association between IL-18 and pSS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Six databases, including PubMed, Web of Science, Embase, Ovid Medline, Scopus and China National Knowledge Infrastructure, were searched. The quality of the included studies was assessed using the Newcastle\u2013Ottawa Scale criteria. We analyzed IL-18 concentrations in the serum and tear of pSS patients and healthy controls (HCs), and review the potential mechanism between IL-18 and pSS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Eleven articles were included in this study, which reported IL-18 levels in serum and tear of pSS patients and HCs. IL-18 levels in pSS patients were significantly higher than those in HCs (standard mean difference\u2005=\u20051.28, 95% confidence interval 0.75\u20131.82,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), with substantial heterogeneity (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u200590%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001) among the studies. The level of IL-18 in serum was analyzed separately and was also higher than those in HCs (standard mean difference\u2005=\u20051.28, 95% confidence interval 0.68\u20131.88,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001), with significant heterogeneity (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2005=\u200591%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). Apart from that, the potential pathogenesis of pSS was concluded comprehensively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>IL-18 abundance was evidently elevated in pSS patients and can thus likely be used as a reliable biomarker to monitor and track the progression of pSS, and further to become a good target for treatment of pSS patient.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000041919","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:05:50Z","timestamp":1743033950000},"page":"e41919","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Expression of interleukin-18 in primary Sj\u00f6gren syndrome and its potential mechanisms with disease: A systematic review and meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Ying","family":"Deng","sequence":"first","affiliation":[{"name":"National Center for Birth Defect Monitoring, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijue","family":"Wang","sequence":"additional","affiliation":[{"name":"National Center for Birth Defect Monitoring, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"West China Hospital of Stomatology, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijuan","family":"Cheng","sequence":"additional","affiliation":[{"name":"National Center for Birth Defect Monitoring, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lei","sequence":"additional","affiliation":[{"name":"National Center for Birth Defect Monitoring, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"},{"name":"West China Hospital of Stomatology, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyu","family":"Luo","sequence":"additional","affiliation":[{"name":"National Center for Birth Defect Monitoring, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Gu","sequence":"additional","affiliation":[{"name":"National Center for Birth Defect Monitoring, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Cai","sequence":"additional","affiliation":[{"name":"National Center for Birth Defect Monitoring, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Renal and Endocrinology, Qin Huang Hospital, Xi\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6184-6216","authenticated-orcid":false,"given":"Nannan","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Center for Birth Defect Monitoring, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261109","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome.","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20261109","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis.","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R3-20261109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coms.2013.09.004","article-title":"Oral complications of Sj\u00f6gren\u2019s syndrome.","volume":"26","author":"Nape\u00f1as","year":"2014","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"R4-20261109","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s10067-022-06210-2","article-title":"Elevated CXCL13 in primary Sj\u00f6gren\u2019s syndrome and its correlation with disease activity: a systematic review and meta-analysis.","volume":"41","author":"Zhu","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"Suppl 6","key":"R5-20261109","doi-asserted-by":"crossref","first-page":"vi53","DOI":"10.1093\/rheumatology\/keab466","article-title":"New developments in Sjogren\u2019s syndrome.","volume":"60","author":"Thalayasingam","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R6-20261109","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.autrev.2017.07.012","article-title":"International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren\u2019s syndrome)? The unmet needs and the clinical grey zone in autoimmune disease management.","volume":"16","author":"Giacomelli","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R7-20261109","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease.","volume":"22","author":"Negrini","year":"2022","journal-title":"Clin Exp Med"},{"issue":"Suppl 126","key":"R8-20261109","first-page":"3","article-title":"One year in review 2020: pathogenesis of primary Sj\u00f6gren\u2019s syndrome.","volume":"38","author":"Bombardieri","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"R9-20261109","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren\u2019s syndrome.","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2249.2012.04606.x","article-title":"Selective localization of T helper subsets in labial salivary glands from primary Sjogren\u2019s syndrome patients.","volume":"169","author":"Maehara","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"R11-20261109","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/s10165-009-0160-6","article-title":"A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis.","volume":"19","author":"Aramaki","year":"2009","journal-title":"Mod Rheumatol"},{"key":"R12-20261109","doi-asserted-by":"crossref","first-page":"919973","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment.","volume":"13","author":"Ihim","year":"2022","journal-title":"Front Immunol"},{"key":"R13-20261109","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.0602313","article-title":"Interleukin-18.","volume":"73","author":"Gracie","year":"2003","journal-title":"J Leukoc Biol"},{"key":"R14-20261109","first-page":"1","article-title":"Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus.","volume":"17","author":"Rezaieyazdi","year":"2021","journal-title":"ARYA Atheroscler"},{"key":"R15-20261109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1468-3083.2003.00647.x","article-title":"Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations.","volume":"17","author":"Gangemi","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R16-20261109","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/jir.2011.0050","article-title":"Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis.","volume":"31","author":"Volin","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"R17-20261109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/14397595.2015.1021409","article-title":"High circulating level of interleukin-18 in patients with primary Sjogren\u2019s syndrome is associated with disease activity.","volume":"26","author":"Chen","year":"2016","journal-title":"Mod Rheumatol"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/jim-2016-000301","article-title":"Elevated IL-37, IL-18 and IL-18BP serum concentrations in patients with primary Sjogren\u2019s syndrome.","volume":"65","author":"Liuqing","year":"2017","journal-title":"J Investig Med"},{"key":"R19-20261109","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/path.4848","article-title":"Proinflammatory effect of high-mobility group protein B1 on keratinocytes: an autocrine mechanism underlying psoriasis development.","volume":"241","author":"Zhang","year":"2017","journal-title":"J Pathol"},{"key":"R20-20261109","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range.","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R21-20261109","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cca.2017.09.019","article-title":"Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sj\u00f6gren\u2019s syndrome.","volume":"474","author":"Kim","year":"2017","journal-title":"Clin Chim Acta"},{"key":"R22-20261109","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00296-018-4063-8","article-title":"Smoking, disease characteristics and serum cytokine levels in patients with primary Sj\u00f6gren\u2019s syndrome.","volume":"38","author":"Olsson","year":"2018","journal-title":"Rheumatol Int"},{"key":"R23-20261109","first-page":"156890","article-title":"IL-18 Serum level in adult onset still\u2019s disease: a marker of disease activity.","volume":"2012","author":"Colafrancesco","year":"2012","journal-title":"Int J Inflam"},{"key":"R24-20261109","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2249.2004.02562.x","article-title":"Relationship between serum levels of IL-18 and IgG1 in patients with primary Sj\u00f6gren\u2019s syndrome, rheumatoid arthritis and healthy controls.","volume":"137","author":"Eriksson","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R25-20261109","doi-asserted-by":"crossref","first-page":"R447","DOI":"10.1186\/ar1209","article-title":"Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sj\u00f6gren\u2019s syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.","volume":"6","author":"Bombardieri","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"R26-20261109","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.lab.2006.01.001","article-title":"Characterization of peripheral natural killer cells in primary Sj\u00f6gren\u2019s syndrome: impaired NK cell activity and low NK cell number.","volume":"147","author":"Izumi","year":"2006","journal-title":"J Lab Clin Med"},{"key":"R27-20261109","first-page":"288","article-title":"Serum interleukin-18 level determination and significance in patients with primary Sj\u00f6gren\u2019s syndrome.","volume":"5","author":"Chai","year":"2011","journal-title":"Chin J Allergy Clin Immunol"},{"key":"R28-20261109","doi-asserted-by":"crossref","first-page":"e0126277","DOI":"10.1371\/journal.pone.0126277","article-title":"Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients.","volume":"10","author":"Niu","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl 133","key":"R29-20261109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.55563\/clinexprheumatol\/fp741f","article-title":"Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjogren\u2019s syndrome.","volume":"39","author":"Loureiro-Amigo","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"R30-20261109","doi-asserted-by":"crossref","first-page":"487","DOI":"10.21037\/atm-22-1494","article-title":"Identification of immune-related diagnostic markers in primary Sjogren\u2019s syndrome based on bioinformatics analysis.","volume":"10","author":"Zeng","year":"2022","journal-title":"Ann Transl Med"},{"key":"R31-20261109","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1600-0528.2002.017418.x","article-title":"Pathophysiological roles of interleukin-18 in inflammatory liver diseases.","volume":"174","author":"Tsutsui","year":"2000","journal-title":"Immunol Rev"},{"key":"R32-20261109","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells.","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"R33-20261109","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/joim.12631","article-title":"The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin\u2019s lymphoma in Sjogren\u2019s syndrome: a prospective, observational, single-centre study.","volume":"282","author":"Baldini","year":"2017","journal-title":"J Intern Med"},{"key":"R34-20261109","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.4049\/jimmunol.167.11.6568","article-title":"Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells.","volume":"167","author":"Sugawara","year":"2001","journal-title":"J Immunol"},{"key":"R35-20261109","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.4049\/jimmunol.1202121","article-title":"Cutting edge: FAS (CD95) mediates noncanonical IL-1beta and IL-18 maturation via caspase-8 in an RIP3-independent manner.","volume":"189","author":"Bossaller","year":"2012","journal-title":"J Immunol"},{"key":"R36-20261109","doi-asserted-by":"crossref","first-page":"110542","DOI":"10.1016\/j.biopha.2020.110542","article-title":"Role of the NLRP3 inflammasome in autoimmune diseases.","volume":"130","author":"Li","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R37-20261109","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2018.0401","article-title":"Interleukin-18: a regulator of cancer and autoimmune diseases.","volume":"28","author":"Esmailbeig","year":"2017","journal-title":"Eur Cytokine Netw"},{"key":"R38-20261109","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary Sjogren\u2019s syndrome.","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"R39-20261109","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.autrev.2018.05.005","article-title":"Clinical and immunological parameters of Sjogren\u2019s syndrome.","volume":"17","author":"Psianou","year":"2018","journal-title":"Autoimmun Rev"},{"key":"R40-20261109","first-page":"63","article-title":"Association of mast cells with fibrosis and fatty infiltration in the minor salivary glands of patients with Sjogren\u2019s syndrome.","volume":"16","author":"Skopouli","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"R41-20261109","doi-asserted-by":"crossref","first-page":"e12649","DOI":"10.1111\/sji.12649","article-title":"Expression of interleukin-17 in primary Sjogren\u2019s syndrome and the correlation with disease severity: a systematic review and meta-analysis.","volume":"87","author":"Zhang","year":"2018","journal-title":"Scand J Immunol"},{"key":"R42-20261109","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cyto.2013.04.029","article-title":"Principal role of IL-12p40 in the decreased Th1 and Th17 responses driven by dendritic cells of mice lacking IL-12 and IL-18.","volume":"63","author":"Lim","year":"2013","journal-title":"Cytokine"},{"key":"R43-20261109","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2018.12.024","article-title":"Inflammasome activation and Th17 responses.","volume":"107","author":"Deng","year":"2019","journal-title":"Mol Immunol"},{"key":"R44-20261109","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.12998\/wjcc.v12.i30.6361","article-title":"Overview of emerging therapies for demyelinating diseases.","volume":"12","author":"Medina","year":"2024","journal-title":"World J Clin Cases"},{"key":"R45-20261109","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jocn.2022.03.043","article-title":"Inflammation and the role of infection: complications and treatment options following neurotrauma.","volume":"100","author":"Clark","year":"2022","journal-title":"J Clin Neurosci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041919","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:00:46Z","timestamp":1794247246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041919","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}